Skip to content
10-Q

Quarterly Report

Cantabio Pharmaceuticals Inc.

0001424884-17-000069

← back to feed
Filed
Aug 14, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · Jun 30, 2017 27.13M sh
Stockholders Equity Q1 2018 · Jun 30, 2017 −$1.13M
Stockholders Equity Q1 2018 · Mar 31, 2017 −$853.92K
Current Liabilities Q1 2018 · Jun 30, 2017 $1.14M
Current Liabilities Q1 2018 · Mar 31, 2017 $887.45K
Total Liabilities Q1 2018 · Jun 30, 2017 $1.14M
Total Liabilities Q1 2018 · Mar 31, 2017 $887.45K
Current Assets Q1 2018 · Jun 30, 2017 $5K
Current Assets Q1 2018 · Mar 31, 2017 $33.52K
Total Assets Q1 2018 · Jun 30, 2017 $5K
Total Assets Q1 2018 · Mar 31, 2017 $33.52K
Operating Cash Flow Q1 2018 · Jun 30, 2016 −$240.22K
Cash And Equivalents Q1 2018 · Jun 30, 2016 $195.6K
Cash And Equivalents Q1 2018 · Mar 31, 2016 $52.11K
Sga Expense Q1 2018 · Jun 30, 2016 $154.33K
Rd Expense Q1 2018 · Jun 30, 2016 $112.73K
Net Income Q1 2018 · Jun 30, 2016 −$265.87K